The review performance goals for manufacturing supplements that do not require FDA approval before the changes they specify can be enacted did not change over the five years of PDUFA II. For manufacturing supplements that do require FDA's approval before the changes can be enacted, the goal times decreased from 6 months for FY 1998 submissions to 4 months for FY 2002 submissions.
Goals |
On-Time Performance by Submission Year |
|||||
---|---|---|---|---|---|---|
FY 98 |
FY 99 |
FY 00 |
FY 01 |
FY 02 |
||
Prior approval not required |
6 months |
90% on time |
90% |
90% |
90% |
90% |
Prior approval required |
6 months |
90% |
90% |
90% |
90% |
NA |
4 months | NA | 30% | 50% | 70% | 90% |
Workload -- Manufacturing supplements filed (Prior Approval / No Prior Approval):
|
FY 98 |
FY 99 |
FY 00 |
FY 01 |
FY 02 4 |
---|---|---|---|---|---|
to NDAs |
1,463 |
1,459 (900/559) |
1,438 (684/754) |
1,474 (579/895) |
1,753 (622/1,131) |
to BLAs |
371 |
477 (259/218) |
587 (239/348) |
591 (185/406) |
717 (217/500) |
PDUFA total |
1,834 |
1,936 (1,159/777) |
2,025 (923/1,102) |
2,065 (764/1,301) |
2,470 (839/1,631) |
FY 2001 Submissions
Ninety-seven percent of the manufacturing supplements submitted in FY 2001
that did not require prior FDA approval were reviewed within 6 months. That
level of performance exceeded the 90 percent on-time review goal.
Ninety-seven percent of the manufacturing supplements submitted in FY 2001 that
required prior FDA approval also were reviewed within 6 months. Eighty-six percent
of these were reviewed within 4 months. That level of performance exceeded FY
2001's goals of 90 percent and 70 percent respectively.
FY 01 Submissions
|
Reviewed and acted upon |
Number on time |
Percent on time |
|
---|---|---|---|---|
Prior approval not required |
6 months |
1301 |
1260 |
97 |
Prior approval required |
6 months |
764 |
744 |
97 |
4 months | 764 | 657 | 86 |
FY 2002 Submissions
As of September 30, 2002, almost 53 percent of the manufacturing supplements that do not require prior approval, and over 70 percent of those that do require prior approval had been reviewed. Ninety-eight percent those not requiring prior approval had been reviewed within the 6-month goal, and 95 percent of those that do require prior approval had been reviewed within the 4-month goal. Although it is too early to make a final determination with only 58 percent of the submissions reviewed, performance in both categories is well above the FY 2002 review goals.
FY 02 Submissions
|
Reviewed and acted upon |
Number on time |
Percent on time |
|
---|---|---|---|---|
Prior approval not required |
6 months |
857 |
843 |
98 |
Prior approval required |
4 months |
585 |
556 |
95 |
FDA Home Page | Search | A-Z
Index | Site Map | Contact FDA
FDA/Office of Planning
Web page created by cm 2003-MAR-15.